AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT04924530 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Sucrose
Description: Co-ingestion of sucrose with a high fat meal
Study NCT04924530 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lactose
Description: Co-ingestion of lactose with a high fat meal
Study NCT06447779 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Recombinant Zoster Vaccine (CHO Cell)
Description: 0.5 mL per dose, containing a total of 50 µg recombinant varicella zoster virus glycoprotein E, adjuvanted with MA105.~Intramuscular injection
Study NCT06447779 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: NaCl solution Placebo
Description: 0.5 mL per dose, containing 4.5 mg sodium chloride. Intramuscular injection
Study NCT05511727 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: single versus double Foley's catheter in pre-induction cervical ripening
Description: The single balloon catheter (i.e. Foley catheter \[FC\]) and Cook cervical ripening balloon have been the most commonly used mechanical method
Study NCT06486662 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OM-85-IN
Description: Participants will receive a Single Ascending Dose (SAD): 1 day single dose treatment and Multiple Ascending Doses (MAD): 16 days multiple dose treatment of OM-85-IN
Study NCT06214507 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: No intervention
Study NCT06345339 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Armour Thyroid
Description: Oral Capsule or Tablet
Study NCT06345339 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levothyroxine
Description: Oral Capsule
Study NCT06454630 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7508
Description: Administered by single intravenous (IV) dose
Study NCT06454630 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enoxaparin
Description: Administered by subcutaneous (SC) dose daily through the time of venography (or day 12, whichever is earlier)
Study NCT05624450 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tozorakimab
Description: Single IV dose of tozorakimab on Day 1.
Study NCT05624450 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Single IV dose of matching placebo on Day 1.
Study NCT05318898 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Vegetal protein
Description: Nutritional recommendations will be given to ensure that the patient consumes a regular diet where the protein intake will be mostly from vegetal protein sources
Study NCT05318898 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Animal protein
Description: Nutritional recommendations will be given to ensure that the patient consumes a regular diet where the protein intake will be mostly from animal protein sources.
Study NCT05887882 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Universal Donor (UD) Transforming growth factor beta imprinting (TGFβi) Natural Killer (NK) Cells
Description: The TGFβi NK cell product will be manufactured in the Cell Therapy Laboratory at Nationwide Children's Hospital and given via infusion.
Study NCT05887882 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Implantation
Description: Undergo placement of Ommaya reservoir
Study NCT05887882 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging (MRI)
Description: Imaging procedure
Study NCT05887882 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT06486662 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive a Single Ascending Dose (SAD): 1 day single dose treatment and Multiple Ascending Doses (MAD): 16 days multiple dose treatment of Placebo
Study NCT06347315 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: BrainXpert
Description: sachet/stickpack of 25 g, has no preservatives, no flavors, no sweeteners, and no colorants.
Study NCT06347315 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: high-oleic acid sunflower oil as a calorie-equivalent, non-ketogenic vegetable oil, non added vitamin product will also be provided in a powder format in a sachet/stickpack of 25 g.
Study NCT05326165 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Juzo Compression Sleeve and Glove
Description: Elasticized garment sized for arm and hand to create pressure to reduce swelling
Study NCT05326165 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Compression Sleeve Sensor
Description: Small device embedded within compression sleeve garment collecting usage information
Study NCT04804241 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Senicapoc
Description: 10 mg oral tablet
Study NCT05798429 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: compassion education
Description: 6 weeks of compassion training
Study NCT04804241 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Tablet
Description: Placebo Oral Tablet
Study NCT06281080 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: En-Bloc Resection of Bladder Tumours
Description: Patients underwent En-Bloc Resection of Bladder Tumours using Agilis Robotic System.
Study NCT04345913 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biopsy
Description: Undergo biopsy
Study NCT04345913 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy
Study NCT04345913 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT04345913 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood sample collection
Study NCT04345913 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Computed Tomography
Description: Undergo CT scan
Study NCT04345913 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan
Study NCT04345913 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Copanlisib Hydrochloride
Description: Given IV
Study NCT04345913 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Eribulin Mesylate
Description: Given IV
Study NCT04345913 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eribulin Mesylate
Description: Given IV
Study NCT04345913 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT04345913 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT05133453 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pirfenidone
Description: drug intake three times daily for one year
Study NCT05924295 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Ketone Supplement
Description: Participants will be given 360mg/kg
Study NCT06481891 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sotagliflozin
Description: Sotagliflozin will be administered as a tablet(s), orally once daily.
Study NCT06481891 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered as a tablet(s) (identical to the sotagliflozin tablet in appearance), orally once daily.
Study NCT06038396 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RC118
Description: Dose A or dose B, Q2W
Study NCT06038396 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Toripalimab
Description: Fixed dose, Q3W
Study NCT06038396 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RC148
Description: Fixed dose, Q3W Other Names: RC148 injection
Study NCT06469281 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 27T51
Description: Intravenous (IV) infusion
Study NCT06469281 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: IV infusion
Study NCT06469281 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: IV Infusion
Study NCT05633654 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sacituzumab govitecan-hziy (SG)
Description: Administered intravenously
Study NCT05633654 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Administered intravenously
Study NCT05633654 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: Administered intravenously
Study NCT05633654 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Capecitabine
Description: Tablets administered orally
Study NCT06432699 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: micro osteoperforation
Description: one side used for mops while other side will be control in same patient
Study NCT05858281 — intervention group
Intervention type: BEHAVIORAL
Intervention: Survey
Description: Black adolescent girls (aged 12-17) will participate in an online survey and will be asked questions regarding their strengths, family, school and community experiences, sexual education knowledge, physical health and mental wellbeing, etc.
Study NCT05858281 — intervention group
Intervention type: BEHAVIORAL
Intervention: Interviews
Description: Parents/guardians of Black girls (aged 12-17) and Black emerging adult women aged 18-22 will participate in individual interviews and will be asked questions about their understanding of Black girls' strengths and resources.
Study NCT05858281 — intervention group
Intervention type: BEHAVIORAL
Intervention: Focus group
Description: Black adolescent girls (aged 12-17) will participate in a focus group and will be asked questions regarding their strengths, family, school and community resources, etc.
Study NCT05517811 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: TEG indices
Description: Blood samples
Study NCT05825768 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Breast MRI
Description: Breast Magnetic Resonance Imaging prior to breast conserving surgery with and without intravenous contrast agent.
Study NCT05825768 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: standard breast imaging
Description: The control group that receives standard preoperative imaging only (breast ultrasound and mammography)
Study NCT05825768 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: standard breast imaging
Description: The control group that receives standard preoperative imaging only (breast ultrasound and mammography)
Study NCT06487208 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Use of a digital cognitive aid in order to anticipate a critical situation
Description: Use of a digital cognitive aid in order to anticipate a critical situation
Study NCT06487208 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: No intervention
Study NCT05539365 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Alpha-type-1 Polarized Dendritic Cells
Description: Given IT
Study NCT05539365 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biopsy
Description: Undergo biopsy
Study NCT05539365 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT scan
Study NCT05539365 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Leukapheresis
Description: Undergo leukapheresis
Study NCT05539365 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT05539365 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies
Study NCT05928585 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HIB210
Description: Experimental monoclonal antibody
Study NCT05928585 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05754333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: pudexacianinium chloride
Description: Intravenous
Study NCT06430333 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Perinatal Understanding of Mindful Awareness for Sleep (PUMAS)
Description: Mindfulness-based sleep program for pregnant women.
Study NCT06430333 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment-as-usual (TAU)
Description: Usual practices from real-world care experiences.
Study NCT05502718 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Stretching and Strengthening Exercises
Description: The patients in the study group will be given exercise videos. These exercise videos will be selected in accordance with the patient's cervical dystonia type (Torticollis, laterocollis, retrocollis, anterocollis). During the exercises, stretching exercises will be applied to the muscle groups that cause dystonia, and isometric strengthening exercises will be applied to the contralateral muscle groups. Videos including breathing exercises and rhythmic coordination exercises will also be given to all patients in the study and control groups. Patients will be asked to do these exercises for 10 repetitions, three times a day, five days a week. Patients will be asked to mark after each exercise on the exercise chart prepared to determine continuity and compliance with exercise. Patients will be called and followed up on a weekly basis with the exercise chart given to the patients and by telephone.
Study NCT05502718 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Breathing and Rhythmic Coordination Exercises
Description: The patients in the study group will be given exercise videos prepared in the Department of Physical Medicine and Rehabilitation of Ankara University Faculty of Medicine. . Videos including breathing exercises and rhythmic coordination exercises will also be given to all patients in the study and control groups. Patients will be asked to do these exercises for 10 repetitions, three times a day, five days a week.
Study NCT05502718 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Breathing and Rhythmic Coordination Exercises
Description: The patients in the study group will be given exercise videos prepared in the Department of Physical Medicine and Rehabilitation of Ankara University Faculty of Medicine. . Videos including breathing exercises and rhythmic coordination exercises will also be given to all patients in the study and control groups. Patients will be asked to do these exercises for 10 repetitions, three times a day, five days a week.
Study NCT06296368 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preference Reporting to Improve Management and Experience (PRIME)
Description: PRIME is a decision support tool that uses best-worst scaling to provide a personalized report to providers and patients of their most important treatment priorities
Study NCT05141708 — intervention group
Intervention type: DRUG
Intervention: Talazoparib
Description: Receipt of talazoparib as treatment for HER2-negative metastatic breast cancer with germline BRCA1/2 mutations anytime between January 1, 2018 and September 30, 2020
Study NCT05275478 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TNG908
Description: TNG908, a selective PRMT5 inhibitor, will be administered orally
Study NCT05924295 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Beverage Tolerability Questionnaire (BTQ) and satiety visual analogue scale
Description: Beverage Tolerability Questionnaire (BTQ) and satiety visual analogue scale will be administered at beginning and end of testing day to tests palatability of supplement
Study NCT05924295 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Blood Draw
Description: IV cannula will be inserted at the start of Test Day, and removed at the end of Test Day. Blood samples will be collected at 7 timepoints (possibly 1 more). Cannula will be flushed with a small volume of saline after each sample to maintain patency.
Study NCT05924295 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Urine Analysis
Description: Prior to consumption of the Study Product, participants will be asked to completely void bladder. And hydration status will be determined via urine specific gravity (USG) reporting \<1.025. Urine passed after the ingestion of the study product will be collected in a plastic container; participants will be asked to void their bladder and collect urine at the end of the test day. The volume produced will be recorded at the end of the study and aliquots will be frozen and stored for future analysis
Study NCT05851443 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: povorcitinib
Description: povorcitinib
Study NCT05804656 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CKDB-501A
Description: Intramuscular injection CKDB-501A
Study NCT05804656 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Botox®
Description: Intramuscular injection Botox®
Study NCT05478434 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cortico-cortical stimulation plus robot-assisted therapy
Description: 15 sessions of cortico-cortical stimulation between the PPC and the M1 of the lesioned hemisphere and robot-assisted therapy. Paired-pulse stimulation (PAS) technique, with 5ms inter-stimulus time between the two areas (PPC to M1), will be done through two high-power Magstim 200 machines (Magstim® Rapid²). To stimulate the M1 area, the coil will be placed tangentially to the scalp at a 45° angle to the midline, to stimulate the PPC area the center of the coil will be positioned over P4 (10-20 EEG system) tangentially to the skull with the handle pointing downward and slightly medial (10°). Robot-assisted therapy will be performed with an Armeo® Power II (Hocoma), an integrative system composed by a robotic exoskeleton device connected to a laptop for the audio-visual biofeedback for the upper limb therapy.
Study NCT05478434 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham cortico-cortical stimulation plus robot-assisted therapy
Description: 15 sessions of sham cortico-cortical stimulation between the PPC and the M1 of the lesioned hemisphere and robot-assisted therapy. Sham paired-pulse stimulation (PAS) will be done through two high-power Magstim 200 machines (Magstim® Rapid²). To simulate the real stimulation, the coils will placed in the same sites with different inclination respect to the scalp (90°). Robot-assisted therapy will be performed with an Armeo® Power II (Hocoma), an integrative system composed by a robotic exoskeleton device connected to a laptop for the audio-visual biofeedback for the upper limb therapy.
Study NCT05594927 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Icaritin
Description: 600 mg (6 x 100 mg capsules) icaritin administered orally twice daily (30 minutes after breakfast and dinner, respectively) until treatment discontinuation criteria are met.
Study NCT05594927 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Huachansu
Description: 1200 mg (4 x 300 mg tablets) huachansu administered orally three times a day (30 minutes after breakfast, lunch and dinner, respectively) until treatment discontinuation criteria are met.
Study NCT05749510 — intervention group
Intervention type: OTHER
Intervention: NCRT+TME
Description: The eligible patients who voluntarily sign the consent form will undergo NCRT and TME according to treatment guidelines.
Study NCT05921682 — intervention group
Intervention type: OTHER
Intervention: observation
Description: This study is an observational study. Patients will receive conventional cooling measures and organ function support.
Study NCT05016661 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ABP-450
Description: ABP-450 (prabotulinumtoxinA) contains a 900 kDa botulinum toxin type-A complex produced by the bacterium Clostridium botulinum.
Study NCT06643234 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ventral hernia repair
Description: Comparative between both techniques
Study NCT05851443 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: placebo
Study NCT05851443 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ICS-LABA
Description: Background Therapy
Study NCT05450601 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HPP2104-2
Description: Placebo drug. Take once daily for 6 weeks orally
Study NCT05851443 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ICS-LABA
Description: Background Therapy
Study NCT06049784 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Visual Biofeedback using self operated home ultrasound device
Description: participants will receive a handheld home ultrasound device, learning to perform self-biofeedback at home. Session records will be sent electronically to the sonographer for assessment and feedback.
Study NCT06049784 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Visual Biofeedback using ultrasound at hospital
Description: A single ultrasound biofeedback session using Transperineal Ultrasound will guide maternal pushing.
Study NCT04934384 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: prehospital extended focused assessment sonography for trauma
Description: Sonographic procedure performed in the prehospital environment aiming at evaluating peritoneal free fluid in trauma patients
Study NCT04916366 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Kinesio taping
Description: Kinesio taping in a bandage to treat musculoskeletal pain.